Skip to main content
Veterinary Medicines

Animeloxan, 20 mg/ml, solution for injection for cattle, pigs and horses

Authorised
  • Meloxicam

Product identification

Medicine name:
Animeloxan, 20 mg/ml, solution for injection for cattle, pigs and horses
Animeloxan, 20 mg/ml, solution for injection for cattle, pigs and horses
Active substance:
  • Meloxicam
Target species:
  • Cattle
  • Horse
  • Pig
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Meloxicam
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        15
        day
    • Horse
      • Milk
        no withdrawal period
      • Meat and offal
        5
        day
  • Subcutaneous use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        15
        day
  • Intramuscular use
    • Pig
      • Meat and offal
        8
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AC06
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • (ID4): 1 unspecified outer container with 12 Vial (Glass) with 100 millilitre(s) (1200 millilitre(s))
  • (ID3): 1 unspecified outer container with 12 Vial (Glass) with 50 millilitre(s) (600 millilitre(s))
  • (ID2): 1 unspecified outer container with 1 Vial (-) with 100 millilitre(s) (100 millilitre(s))
  • (ID1): 1 unspecified outer container with 1 Vial (-) with 50 millilitre(s) (50 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • Industrial Veterinaria S.A.
  • aniMedica Herstellungs GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10826/025/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0311/002
Concerned member states:
  • Austria
  • Bulgaria
  • Cyprus
  • Czechia
  • Estonia
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download

Combined File of all Documents

English (PDF)
Published on: 5/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."